FDA Inspection 1035715 — Peng Xiang
The FDA completed an inspection of Peng Xiang on Dec 14, 2017 in Hunan 410004. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 14, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hunan 410004 (China)
Additional Details
Clinical Investigator (CI)